Found: 29
Select item for more details and to access through your institution.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 4, p. 837, doi. 10.3390/ijms18040837
- By:
- Publication type:
- Article
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 415, doi. 10.3390/ijms18020415
- By:
- Publication type:
- Article
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 691, doi. 10.1111/bjh.15824
- By:
- Publication type:
- Article
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919900872
- By:
- Publication type:
- Article
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 11, p. 1825, doi. 10.1007/s00277-014-2126-9
- By:
- Publication type:
- Article
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting: R-EFECT study.
- Published in:
- Wiener Klinische Wochenschrift, 2020, v. 132, n. 15/16, p. 415, doi. 10.1007/s00508-020-01690-1
- By:
- Publication type:
- Article
Correction to: Ruxolitinib therapy formyelofibrosis in Austria.
- Published in:
- Wiener Klinische Wochenschrift, 2019, v. 131, n. 1/2, p. 47, doi. 10.1007/s00508-018-1428-7
- By:
- Publication type:
- Article
Ruxolitinib therapy for myelofibrosis in Austria.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 17/18, p. 495, doi. 10.1007/s00508-018-1365-5
- By:
- Publication type:
- Article
Austrian recommendations for the management of polycythemia vera.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 17/18, p. 535, doi. 10.1007/s00508-018-1359-3
- By:
- Publication type:
- Article
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 3/4, p. 115, doi. 10.1007/s00508-018-1315-2
- By:
- Publication type:
- Article
Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.
- Published in:
- Wiener Klinische Wochenschrift, 2017, v. 129, n. 9/10, p. 293, doi. 10.1007/s00508-016-1120-8
- By:
- Publication type:
- Article
10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
- Published in:
- Wiener Klinische Wochenschrift, 2015, v. 127, n. 1/2, p. 12, doi. 10.1007/s00508-014-0627-0
- By:
- Publication type:
- Article
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis.
- Published in:
- Wiener Klinische Wochenschrift, 2013, v. 125, n. 7/8, p. 196, doi. 10.1007/s00508-013-0345-z
- By:
- Publication type:
- Article
First annual report of the Austrian CML registry.
- Published in:
- Wiener Klinische Wochenschrift, 2010, v. 122, n. 19/20, p. 558, doi. 10.1007/s00508-010-1450-x
- By:
- Publication type:
- Article
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.
- Published in:
- Wiener Klinische Wochenschrift, 2008, v. 120, n. 21/22, p. 697, doi. 10.1007/s00508-008-1100-8
- By:
- Publication type:
- Article
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1401, doi. 10.1002/cam4.1980
- By:
- Publication type:
- Article
Three solid malignancies and a myelodysplastic syndrome with a protracted course after kidney transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2014, v. 4, p. 101, doi. 10.2147/BLCTT.S29592
- By:
- Publication type:
- Article
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3).
- Published in:
- Molecular Cytogenetics (17558166), 2018, v. 11, p. 1, doi. 10.1186/s13039-018-0355-7
- By:
- Publication type:
- Article
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 885, doi. 10.1002/ajh.24788
- By:
- Publication type:
- Article
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 288, doi. 10.1002/ajh.23928
- By:
- Publication type:
- Article
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French- American-British and World Health Organization classifications.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0263-4
- By:
- Publication type:
- Article
Azacitidine in patients with WHO-defined AML - Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-32
- By:
- Publication type:
- Article
Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.
- Published in:
- Drugs & Aging, 2015, v. 32, n. 11, p. 891, doi. 10.1007/s40266-015-0312-7
- By:
- Publication type:
- Article
BCR-ABL-negative chronic myeloid leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2007, v. 2, n. 2, p. 75, doi. 10.1007/s11899-007-0011-5
- By:
- Publication type:
- Article